Product image of Glimepirida Ciclum (Glimepiride) supplied by GNH India

Glimepirida Ciclum

Active Ingredient:
Glimepiride
Origin:
EU

Glimepirida Ciclum (Glimepiride)

Glimepirida Ciclum is a prescription oral medication that contains the active ingredient glimepiride. The product is marketed in the European Union and is classified as a sulfonylurea antidiabetic agent. While the specific dosage strength and dosage form are not disclosed, it is intended for oral administration to help manage blood glucose levels in adults with type 2 diabetes mellitus.

Manufacturer / TM Owner

Ciclum Farma Unipessoal Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepirida Ciclum is indicated for the treatment of type 2 diabetes mellitus as part of a comprehensive diabetes management plan. It may be used when diet, exercise, and other oral agents are insufficient to achieve glycemic control.

  • Improves fasting and post‑prandial blood glucose levels.
  • Can be combined with metformin or other oral antidiabetics.
  • May be prescribed when lifestyle modifications alone are inadequate.
  • Used in adults diagnosed with type 2 diabetes.
  • Supports overall glycemic management alongside diet and exercise.

Side Effects

Glimepirida Ciclum may cause a range of side effects, some of which are more frequently reported than others.

Common

  • Mild hypoglycemia (low blood sugar)
  • Headache
  • Dizziness
  • Nausea or abdominal discomfort
  • Weight gain
  • Skin rash or itching

Serious

  • Severe hypoglycemia requiring assistance
  • Allergic reactions such as swelling of the face, lips, or throat
  • Hepatic dysfunction indicated by jaundice
  • Hematologic abnormalities like leukopenia or thrombocytopenia

Precautions & Warnings

Before starting Glimepirida Ciclum, certain precautions should be considered to ensure safe use.

  • Assess renal and hepatic function, as impairment may affect drug clearance.
  • Monitor blood glucose regularly to detect hypoglycemia.
  • Use cautiously in elderly patients who may be more susceptible to low blood sugar.
  • Review any history of cardiovascular disease, as sulfonylureas can affect cardiac outcomes.
  • Avoid use during pregnancy or breastfeeding unless clearly indicated by a physician.
  • Discontinue if signs of severe allergic reaction appear.

Avoid Interactions

Glimepirida Ciclum can interact with several medications, influencing its efficacy or safety profile.

Avoid

  • Other sulfonylureas or insulin, which may increase the risk of hypoglycemia.
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that can raise glimepiride levels.
  • MAO‑B inhibitors, which may potentiate hypoglycemic effects.

Use with caution

  • Beta‑blockers, which can mask hypoglycemia symptoms.
  • Thiazide diuretics, as they may affect glucose tolerance.
  • NSAIDs and aspirin, which can impair renal function and alter drug clearance.

Frequently Asked Questions

Glimepirida Ciclum contains glimepiride as its sole active pharmaceutical ingredient.

Glimepiride stimulates insulin release from pancreatic beta cells by closing ATP‑sensitive potassium channels, which enhances glucose uptake by tissues.

Glimepirida Ciclum is marketed in the EU; availability in other regions depends on local regulatory approvals.

Yes, glimepiride is often combined with metformin to improve glycemic control, but dosing should be individualized by a healthcare professional.

Common side effects include mild hypoglycemia, headache, dizziness, nausea, weight gain, and skin rash.

Serious reactions may involve severe hypoglycemia, allergic swelling of the face or throat, jaundice, or blood‑cell abnormalities; seek medical attention promptly.

The safety of glimepiride in pregnancy has not been established; it should only be used if the potential benefit justifies the potential risk and under medical supervision.

Regular monitoring, including fasting and post‑prandial measurements, is recommended to assess efficacy and detect hypoglycemia.

Avoid concurrent use of other sulfonylureas, insulin, strong CYP2C9 inhibitors, and MAO‑B inhibitors to reduce the risk of excessive hypoglycemia.

Elderly patients may be more prone to hypoglycemia and should start at lower doses with close monitoring.

Renal impairment can alter glimepiride clearance; dose adjustments or alternative therapies may be needed based on kidney function.

Consume fast‑acting carbohydrates such as glucose tablets or fruit juice, and contact a healthcare provider if symptoms persist or worsen.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.